This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Best Value Stocks to Buy for March 1st
by Zacks Equity Research
RCL, RITM and CNO made it to the Zacks Rank #1 (Strong Buy) value stocks list on March 1, 2023.
Are You Looking for a High-Growth Dividend Stock?
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does CNO Financial (CNO) have what it takes? Let's find out.
Are Investors Undervaluing Assurant (AIZ) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Are Investors Undervaluing Allianz (ALIZY) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
AIG Q4 Earnings Beat Estimates on General Insurance Strength
by Zacks Equity Research
AIG's fourth-quarter results benefit from strong underwriting results, partially offset by higher expenses.
Lincoln National (LNC) Q4 Earnings Beat on Group Protection Unit
by Zacks Equity Research
Lincoln National's (LNC) Q4 results indicate favorable Life mortality and disability results, and a decline in overall expenses, partly offset by a lower spread income within the Retirement Plan Services unit.
New Strong Buy Stocks for February 9th
by Zacks Equity Research
PBPB, FUNC, MDC, CNO and HRB have been added to the Zacks Rank #1 (Strong Buy) List on February 9, 2023.
Best Income Stocks to Buy for February 9th
by Zacks Equity Research
FUNC, MDC and CNO made it to the Zacks Rank #1 (Strong Buy) income stocks list on February 9, 2023.
Best Value Stocks to Buy for February 9th
by Zacks Equity Research
CNO, FUNC and HRB made it to the Zacks Rank #1 (Strong Buy) value stocks list on February 9, 2023.
Assurant, Inc. (AIZ) Hits Fresh High: Is There Still Room to Run?
by Zacks Equity Research
Assurant (AIZ) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
CNO Financial (CNO) Q4 Earnings Beat on High Investment Income
by Zacks Equity Research
CNO Financial (CNO) anticipates the effective tax rate for 2024 to be around 23%.
Compared to Estimates, CNO (CNO) Q4 Earnings: A Look at Key Metrics
by Zacks Equity Research
The headline numbers for CNO (CNO) give insight into how the company performed in the quarter ended December 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
CNO Financial (CNO) Q4 Earnings and Revenues Top Estimates
by Zacks Equity Research
CNO (CNO) delivered earnings and revenue surprises of 38.82% and 25.31%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
Cincinnati Financial (CINF) to Report Q4 Earnings: What to Expect
by Zacks Equity Research
Cincinnati Financial's (CINF) fourth-quarter results are likely to reflect the impact of growth initiatives, increased exposure, better pricing and increased property casualty agency, offset by cat loss.
Are Investors Undervaluing CNO Financial Group (CNO) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Can Higher Policy Income Aid CNO Financial's (CNO) Q4 Earnings?
by Zacks Equity Research
CNO Financial's (CNO) Q4 results are expected to benefit on higher variable investment income and a favorable claims experience in its health product suite, partly offset by escalating expenses.
Can Higher Expenses Play Spoilsport for AON's Q4 Earnings?
by Zacks Equity Research
AON's fourth-quarter results are likely to showcase a significant increase in Reinsurance Solutions revenues.
CNO Financial (CNO) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
CNO (CNO) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Will Rising Premiums Drive MetLife's (MET) Q4 Earnings?
by Zacks Equity Research
MetLife's (MET) fourth-quarter results are likely to reflect improving profits from the U.S., Asia and Latin American operations.
Can Aflac's (AFL) Q4 Earnings Beat on Strong US Business?
by Zacks Equity Research
Aflac's (AFL) Q4 results are likely to reflect a well-performing U.S. segment, strong net investment income, and a decline in benefits and claims.
Why You Should Add CNO Financial (CNO) to Your Portfolio Now
by Zacks Equity Research
CNO Financial (CNO) is well-poised for growth in product launches, a diversified product portfolio and the prudent deployment of capital.
CNO (CNO) Upgraded to Strong Buy: Here's Why
by Zacks Equity Research
CNO (CNO) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Is CNO Financial Group (CNO) Stock Undervalued Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
How CNO Financial (CNO) Stock Stands Out in a Strong Industry
by Zacks Equity Research
CNO Financial (CNO) has seen solid earnings estimate revision activity over the past two months, and belongs to a strong industry as well.
Here's Why Hold Strategy is Apt for Prudential Financial (PRU)
by Zacks Equity Research
Prudential Financial (PRU) stands to gain from higher emerging markets earnings, improved spread income, strategic acquisitions, effective capital deployment and a solid financial position.